- Trials with a EudraCT protocol (29)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
29 result(s) found for: Magnesium acetate.
Displaying page 1 of 2.
EudraCT Number: 2012-004178-24 | Sponsor Protocol Number: RP-OSV-02-D | Start Date*: 2013-12-27 |
Sponsor Name:Fresenius Medical Care Deutschland GmbH | ||
Full Title: Study to investigate the therapeutic equivalence of OsvaRen® tablets and OsvaRen® granules | ||
Medical condition: Hyperphosphataemia in end stage renal failure patients on extracorporeal renal replacement therapy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2021-002329-56 | Sponsor Protocol Number: FISIO | Start Date*: 2021-10-19 | |||||||||||
Sponsor Name:Sociedad Española de Medicina Intensiva, Crítica y Unidades Coronarias (SEMICYUC) | |||||||||||||
Full Title: Exploratory study to evaluate the efficacy and safety of nutritionally administering 1.5 g protein/kg/day vs. 1.0 g protein/kg/day in the catabolic phase of the critically ill patient on mechanical... | |||||||||||||
Medical condition: Acquired Weakness in the Intensive Care Unit (DAUCI) of the critically ill patient. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-001378-97 | Sponsor Protocol Number: Ped3CB/P01/06/Mu.B | Start Date*: 2007-08-14 | |||||||||||
Sponsor Name:Baxter SAS | |||||||||||||
Full Title: Safety during use of paediatric triple chamber bag formulas administered IV at a weight dependant dose during 5 consecutive days in paediatric patients up to 18 years requiring parenteral nutrition... | |||||||||||||
Medical condition: The study is not focussed on a particular pathology but rather on the use of triple chamber bags in paediatrics, in any pathology requiring parenteral nutrition | |||||||||||||
|
|||||||||||||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-002589-20 | Sponsor Protocol Number: CALMAG-01 | Start Date*: 2007-12-14 | |||||||||||
Sponsor Name:Fresenius Medical Care Deutschland GmbH | |||||||||||||
Full Title: Evaluation of Calcium Acetate/Magnesium Carbonate (OsvaRen®) compared to Sevelamer (Renagel®) in Haemodialysis Patients | |||||||||||||
Medical condition: Elevated serum phosphate levels (hyperphosphataemia) in patients with chronic renal failure on dialysis (haemodialysis, peritoneal dialysis) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PT (Completed) ES (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-002176-27 | Sponsor Protocol Number: HC-G-H-1505 | Start Date*: 2017-08-30 | |||||||||||
Sponsor Name:Fresenius Kabi Deutschland GmbH | |||||||||||||
Full Title: Pragmatic, prospective, randomized, controlled, double-blind, multicentre, multinational study on the safety and efficacy of a 6% Hydroxyethyl starch (HES) solution versus an electrolyte solution ... | |||||||||||||
Medical condition: Hypovolaemia due to acute blood loss in trauma surgery | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) BE (Completed) CZ (Completed) NL (Completed) ES (Restarted) FR (Ongoing) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-014774-18 | Sponsor Protocol Number: 09063 | Start Date*: 2009-10-29 |
Sponsor Name:University of Nottingham | ||
Full Title: The effects of balanced and unbalanced crystalloids and colloids on serum biochemistry and visceral blood flow: A two-phase, double-blind, randomised cross-over study | ||
Medical condition: This is a healthy volunteer study investigating the effect of balanced and unbalanced fluid infusions on serum electrolytes, osmolality and acid/base balance. In addition we are examining the role ... | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-009893-28 | Sponsor Protocol Number: 16012009 | Start Date*: 2009-04-15 | |||||||||||
Sponsor Name:HUCH, ATEK, TÖÖLÖN SAIRAALA, NEUROKIRURGIAN KLINIKKA | |||||||||||||
Full Title: Tavoite-ohjattu nestehoito vatsa-asennon neurokirurgisen potilaan anestesiassa | |||||||||||||
Medical condition: Kaula- ja lannerangan leikkauspotilaat. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-000861-34 | Sponsor Protocol Number: 2021-000861-34 | Start Date*: 2022-07-01 |
Sponsor Name:Region Ostergotland | ||
Full Title: Comparison of albumin and Ringer´s solution for optimization of the plasma volume and hemodynamics during surgery. | ||
Medical condition: Patients in need of major laparoscopic surgery in the abdomen, lasting longer than 90 minutes | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2016-002162-30 | Sponsor Protocol Number: HC-G-H-1504 | Start Date*: 2017-04-12 | |||||||||||
Sponsor Name:Fresenius Kabi Deutschland GmbH | |||||||||||||
Full Title: Prospective, randomized, controlled, double-blind, multicentre, multinational study on the safety and efficacy of 6% Hydroxyethyl starch (HES) solution versus an electrolyte solution in patients u... | |||||||||||||
Medical condition: Hypovolaemia due to acute blood loss in elective abdominal surgery | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) CZ (Completed) NL (Completed) ES (Restarted) FR (Ongoing) AT (Completed) HR (Completed) RO (Ongoing) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-004340-35 | Sponsor Protocol Number: CAMG-14-I | Start Date*: 2015-03-03 | |||||||||||
Sponsor Name:Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico | |||||||||||||
Full Title: Randomized controlled trial of two different combinations of Calcium-containing Phosphate binders (Ca-PiB) plus non-Calcium-non-Aluminum containing Phosphate binders (no-Ca-Al-PiB): a pharma-econom... | |||||||||||||
Medical condition: Hyperphosphatemia associated with Chronic Kidney Disease (CKD) in patients undergoing hemodialysis. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-003240-30 | Sponsor Protocol Number: CR9304-21 | Start Date*: 2008-12-18 | |||||||||||
Sponsor Name:Cancer Research UK | |||||||||||||
Full Title: A Cancer Research UK Phase I/II Open Label Study to Evaluate the Safety, Endocrine Effects, and Anti-tumour Activity of Abiraterone Acetate (CB7630) in Patients with Oestrogen (ER) or Androgen Rece... | |||||||||||||
Medical condition: Oestrogen (ER) or androgen receptor (AR) positive, advanced or metastatic breast carcinoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-002556-27 | Sponsor Protocol Number: ALBICS | Start Date*: 2016-11-25 | |||||||||||
Sponsor Name:Helsinki University Hospital | |||||||||||||
Full Title: Albumin in cardiac surgery | |||||||||||||
Medical condition: Cardiac surgery with cardiopulmonary bypass operations. Elective and emergency patients. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-003260-32 | Sponsor Protocol Number: 13090 | Start Date*: 2013-12-04 |
Sponsor Name: | ||
Full Title: The Effects of Isovolumetric and Isoeffective Infusions of Colloid Versus Crystalloid on Renal Blood Flow and Cardiac Output | ||
Medical condition: Anaesthesia | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2010-018524-58 | Sponsor Protocol Number: HC-G-H-0904 | Start Date*: 2011-09-12 | |||||||||||
Sponsor Name:B. Braun Melsungen AG | |||||||||||||
Full Title: Prospective controlled double-blind phase III bicentre study on the efficacy and safety of a balanced gelatine solution in combination with a balanced electrolyte solution versus a standard gelatin... | |||||||||||||
Medical condition: acid-base status intraoperatively and postoperatively | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-006153-31 | Sponsor Protocol Number: CSC/P01/07/Mu.F | Start Date*: 2008-04-23 | |||||||||||
Sponsor Name:Baxter R and D Europe SCRL | |||||||||||||
Full Title: Safety and efficacy of subcutaneous (SC) administration of Clinimix N9G15E in elderly patients at risk for malnutrition, at a dose of 1 liter infused over 12 hours for 7 to 10 consecutive days. A p... | |||||||||||||
Medical condition: The population studied will be the elderly population at risk for malnutrition without any predefined pathology at hospital geriatrician wards. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-005325-39 | Sponsor Protocol Number: ELX-NPP-2016-01 | Start Date*: 2016-04-26 | |||||||||||
Sponsor Name:Dr. Antonio Arroyo Sebastián | |||||||||||||
Full Title: A RANDOMIZED, CONTROLLED, CLINICAL TRIAL TO COMPARE PERIPHERAL PARENTERAL NUTRITION (PeriOlimel N4-E) VS CONVENTIONAL FLUID THERAPY IN ENHANCED RECOVERY AFTER SURGERY (ERAS) PROTOCOL IN COLORECTAL ... | |||||||||||||
Medical condition: Cancer colorectal | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-004175-22 | Sponsor Protocol Number: HC-G-H-0803 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:B. Braun Melsungen AG | |||||||||||||
Full Title: PROSPECTIVE, CONTROLLED, DOUBLE-BLIND, RANDOMIZED MULTICENTRIC STUDY ON THE EFFICACY AND SAFETY OF A TARGET CONTROLLED PLASMA VOLUME REPLACEMENT THERAPY WITH A HYPER-ONCOTIC BALANCED HES 130/0.42... | |||||||||||||
Medical condition: Intraoperative plasma volume replacement requirement in elective surgery of the pancreatic head (pylorus preserving pancreatic-duodenectomy, PPPD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-017595-25 | Sponsor Protocol Number: 04-AnIt-09/UKM09_0031 | Start Date*: 2011-02-22 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:University Hospital Muenster | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: Balanced 6 % HES 130/0.4 vs. balanced crystalloid-based infusion in patients undergoing colorectal surgery | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: Patients undergoing colorectal surgery | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2015-000057-20 | Sponsor Protocol Number: HC-G-H-1209 | Start Date*: 2015-11-10 | ||||||||||||||||
Sponsor Name:B. Braun Melsungen AG | ||||||||||||||||||
Full Title: PROSPECTIVE, RANDOMIZED, CONTROLLED, DOUBLE-BLIND, MULTI-CENTRIC, INTERNATIONAL, STUDY ON THE EFFICACY AND SAFETY OF AN EARLY TARGET CONTROLLED PLASMA VOLUME REPLACEMENT THERAPY WITH A BALANCED GEL... | ||||||||||||||||||
Medical condition: Hypovolaemia in Severe Sepsis / Septic Shock | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: HU (Prematurely Ended) CZ (Completed) AT (Prematurely Ended) DE (Prematurely Ended) ES (Prematurely Ended) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-016043-19 | Sponsor Protocol Number: HIPSTER | Start Date*: 2010-04-12 |
Sponsor Name:Charité – University Medicine Berlin | ||
Full Title: Impact of a balanced infusion solution compound of 50% cristalloid and 50% colloid versus a unbalanced infusion solution of 100% cristalloid within a goal-directed hemodynamic protocol on acid-base... | ||
Medical condition: Patients undergoing elective hip replacement surgery will be divided into two groups. In one group an intravenous application of Ringer Baxter Infusionsloesung, in the other group a parallel intra... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
